Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilufar Partovi

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|February 15, 2007
Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis CAnne E Dar Santos, Nilufar Partovi, Jo-Ann E Ford, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2012
Review of boceprevir and telaprevir for the treatment of chronic hepatitis CKyle John Wilby, Nilufar Partovi, Jo-Ann E Ford, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 27, 2005
Documenting drug-related problems with personal digital assistants in a multisite health systemSumit Raybardhan, Robert M Balen, Nilufar Partovi, et al.
Canadian Journal of Kidney Health and Disease|April 12, 2018
Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort AnalysisErin Ready, Kseniya Chernushkin, Nilufar Partovi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 21, 2015
A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney diseaseAnna Maruyama, Nilufar Partovi, Eric M Yoshida, et al.
The Annals of Pharmacotherapy|March 15, 2015
Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant PatientsSarah Burgess, Nilufar Partovi, Eric M Yoshida, et al.
Annals of Hepatology|February 21, 2012
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patientsKyle J Wilby, Erica D Greanya, Jo-Ann E Ford, et al.
The Annals of Pharmacotherapy|August 3, 2006
Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipientsLillian S L Ting, Nilufar Partovi, Robert D Levy, et al.
Therapeutic Drug Monitoring|March 19, 2002
Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipientsMary H H Ensom, Nilufar Partovi, Diane Decarie, et al.
Therapeutic Drug Monitoring|June 4, 2008
Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipientsLillian S L Ting, Nilufar Partovi, Robert D Levy, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|February 15, 2007
Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis CAnne E Dar Santos, Nilufar Partovi, Jo-Ann E Ford, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2012
Review of boceprevir and telaprevir for the treatment of chronic hepatitis CKyle John Wilby, Nilufar Partovi, Jo-Ann E Ford, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 27, 2005
Documenting drug-related problems with personal digital assistants in a multisite health systemSumit Raybardhan, Robert M Balen, Nilufar Partovi, et al.
Canadian Journal of Kidney Health and Disease|April 12, 2018
Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort AnalysisErin Ready, Kseniya Chernushkin, Nilufar Partovi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 21, 2015
A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney diseaseAnna Maruyama, Nilufar Partovi, Eric M Yoshida, et al.
The Annals of Pharmacotherapy|March 15, 2015
Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant PatientsSarah Burgess, Nilufar Partovi, Eric M Yoshida, et al.
Annals of Hepatology|February 21, 2012
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patientsKyle J Wilby, Erica D Greanya, Jo-Ann E Ford, et al.
The Annals of Pharmacotherapy|August 3, 2006
Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipientsLillian S L Ting, Nilufar Partovi, Robert D Levy, et al.
Therapeutic Drug Monitoring|March 19, 2002
Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipientsMary H H Ensom, Nilufar Partovi, Diane Decarie, et al.
Therapeutic Drug Monitoring|June 4, 2008
Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipientsLillian S L Ting, Nilufar Partovi, Robert D Levy, et al.
Pageof 5